HIV / AIDS in the News

Health Policy Watch: African Union pushes for greater domestic spending on health amid reports of huge disruptions to HIV and TB services - European AIDS Treatment Group

 

Forty-Five Years Of HIV/AIDS And We’re Still Ignoring Black Women’s Leadership, Says New Book, Ill Erotics - Forbes

 

Countries in Latin America and the Caribbean helped build the future of HIV prevention. But will they be able to benefit from it? - Unitaid

 

Amid Row Over Exclusion, US Concedes that HIV Approach Needs to Include ‘All People at Risk’ - Health Policy Watch

 

The ‘cruel irony’ of great science, terrible politics and economics in HIV/AIDS treatment and prevention | AIDS 2026 - Managed Healthcare Executive

 

Renee Heffron, Ph.D., M.P.H., on HIV community resilience | AIDS 2026 - Managed Healthcare Executive

 

Lloyd Mulenga, M.B.Ch.B., Ph.D., on HIV prevention funding cuts | AIDS 2026 - Managed Healthcare Executive

 

Lloyd Mulenga, M.B.Ch.B., Ph.D., on Zambia's HIV funding risk | AIDS 2026 - Managed Healthcare Executive

 

Addressing the HIV Epidemic in Eastern Europe and Central Asia - The Borgen Project

 

Renee Heffron, Ph.D., M.P.H., on the case for MK-8527 | IAS 2026 - Managed Healthcare Executive

 

[AIDS 2026] [Press statement] Activists disrupt US Global AIDS Coordinator Jeff Graham at International AIDS Conference - European AIDS Treatment Group

 

Renee Heffron, Ph.D., M.P.H., on choice in HIV prevention | AIDS 2026 - Managed Healthcare Executive

 

[AIDS 2026] [Press release] Merck announces initial access plans for alimatravir, an investigational once-monthly oral HIV PrEP in Phase 3 development - European AIDS Treatment Group

 

New JIAS supplement on vaccines for the elimination of STIs - European AIDS Treatment Group

 

Gilead Targets Black Women With HIV Prevention Campaign 08/03/2026 - MediaPost

 

Opinion | Cuts to anti-AIDS foreign aid take a toll in Africa - The Washington Post

 

Thousands participating in annual HIV and AIDS bike rally from Toronto to Montreal - CTV News

 

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative - simplywall.st

 

IAS: Data revealing the impact of PEPFAR disruptions and advances in long-acting HIV prevention and treatment announced ahead of AIDS 2026 - European AIDS Treatment Group

 

Hope grows as HIV care enters a new era - The Daily Star

 

Avantor (AVTR) Expands NuSil HIV Prevention Partnership With The Population Council - Yahoo Finance

 

Merck Announces Initial Access Plans For Alimatravir, Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis - Pulse 2.0

 

Lenacapavir may slow HIV infections 'but there's not enough' - dw.com

 

Preventing Those Living with HIV from Navigating the Journey Alone: Henrique’s Commitment - Gilead Sciences

 

WATCH: The amazing true story of the flight attendants who smuggled HIV medication to Brazil in the '80s - Queerty

 

The Hope of Organ Donations for People Living With HIV - POZ

 

Aging with HIV: The Latino Commission on AIDS honors National Latino Older Adults & HIV/AIDS Awareness Day - Los Angeles Blade

 

She Wasn't Supposed to Survive. Her Fight Saved Thousands - Haaretz

 

Merck & Co. details access strategy for once-monthly PrEP pill in late-stage testing - FirstWord PHARMA

 

Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion? - simplywall.st